Seeking Alpha


Send Message
View as an RSS Feed
View candooman's Comments BY TICKER:
Latest comments  |  Highest rated
  • Addressing A Major Public Need: The Ocata Preclinical Pipeline, Part 2: Platelet Production [View article]
    Oct 2, 2015. 09:06 AM | 1 Like Like |Link to Comment
  • Addressing A Major Public Need: The Ocata Preclinical Pipeline, Part 2: Platelet Production [View article]
    Call the short, comprehensible and very informative articles a welcome change. You are providing answers to many of my questions and I love it! Thank you Dr Hartman, please keep 'em coming.
    Oct 2, 2015. 09:05 AM | 6 Likes Like |Link to Comment
  • A Possible Cure For Blindness: The Ocata Preclinical Pipeline- Photoreceptor Progenitors [View article]
    Zach, we OCAT followers cannot thank you enough for publishing your articles. After the attempted takedown of OCAT by Mako Research, you are a great relief!

    Thanks again. Two great articles and more coming, wow!
    Sep 30, 2015. 12:05 PM | 15 Likes Like |Link to Comment
  • Light At The End Of The Tunnel For Lightbridge [View article]
    LTBR just concluded the deal for their fuel to be tested in a running reactor in Norway. This is to show that the design of the fuel is sound and materials used are what they should be in actual reactor service. This test will take two years and we do not know if there will be without glitches and successful. Until then, investors are putting their money somewhere else to get returns today.

    The current management is so slow in moving. They should have had this fuel tested and approved by the NRC today. 5 years ago they said they were ready for the actual test but nothing happened. The price reflects the poor quality of LTBR management.
    Sep 29, 2015. 04:31 PM | 1 Like Like |Link to Comment
  • The Drug Carry Trade: Valeant's Massively Leveraged Long-Short Strategy Is About To Unwind [View article]
    Let us see if the Republican chairman agrees to send this letter. If he refuses, then we can assume the Pharma lobby got to him to protect their interest. The Valeant CEO, a Canadian cannot be subpoenad by US Congress. They can force him to testify by threatening him and his executives by barring them from entering the US and arrested if they did. The SEC can open an anti-trust case against them and then ask them to testify. Valeant cannot refuse the SEC.
    Sep 29, 2015. 02:32 PM | 3 Likes Like |Link to Comment
  • Ocata to Present at Ladenburg Thalmann 2015 Healthcare Conference [View article]
    I just clicked on the link and the article comment section is not there. The header above the article indicates there are 103 comments.... which I would like very much to read.
    Sep 24, 2015. 07:43 PM | Likes Like |Link to Comment
  • Ocata to Present at Ladenburg Thalmann 2015 Healthcare Conference [View article]
    NOte that the Mako Research piece referred to by sunwindgo above no longer have a comment section. The 81 previous comments (99% against the article) is no longer accessible.

    Who removed them, Mako? Is SA aware of this? If it was removed with SA approval, we have a big problem. It is called market manipulation. I would advice SA not to participate in it, it is illegal. SA should put back the Comments or take out the article completely or risk being a sued.
    Sep 24, 2015. 12:34 PM | Likes Like |Link to Comment
  • Ocata: Dilution Imminent, SEC Investigation Potentially Underway, Office Appears Empty, Price Target $0.00 [View article]
    Thanks Mako Research for your blog. I noticed you did not disclose if you own shares or have shorted the shares before you issued this blog. I went to the top and to the end of your article a few times and I did not see ANY DISCLOSURES, please explain.

    I want to thank you profoundly for your blog. The last time this stock went down to $3.02 on Aug 17, I missed buying. On Sept 3 it reached $4.67 ($5.11 on Sept 21). Had I not missed buying, then selling on Sept 3, I would have made a 54% profit. I hope, with your blog, the stock will go down in the low $3's again and then I can buy a lot. So, I am hopeful, so hopeful I am thanking you in advance.
    Sep 23, 2015. 12:39 PM | 3 Likes Like |Link to Comment
  • Sirius Announces Extension Of Agreement With Toyota [View article]
    It remains to be seen if the other car manufacturers (Acura, BMW, Honda, Hyundai, Infiniti, Lexus, Nissan ) follow Toyota's lead. If they do, then we will see the revenue blossom.
    Sep 21, 2015. 07:20 PM | 3 Likes Like |Link to Comment
  • MagicJack up 3.5% on new distribution deal with RadioShack [View news story]
    I have one more year to go on my MagicJack GO and I will be renewing for another 5 years. I have the apps on my iPod which allows me to call any number in the US and Canada from any place I happen to be in the world as long as there is wifi. Before the apps came about, I had to bring the dongle and a phone set with me in my travels. Now it is just an iPhone, iPad, iPod or any Android device. My dongle remains plugged into my computer at home.
    Sep 17, 2015. 01:38 PM | Likes Like |Link to Comment
  • Midday Gainers / Losers [View news story]
    ATHX is negotiating with the FDA on a new Ph 3 trial to show it works when applied between 16 and 36 hours after a stroke. Data already showed it is effective when treatment is applied between 24 and 36 hours. Data from the previous Trial showed that it hardly works beyond 36 hours. The original Trial time was 24 to 36 but for lack of patients, was amended to extend to 48 hrs (big mistake).

    The rise of the stock could be the anticipation of an agreement between ATHX and FDA on the trial protocol and end points. If it is, the trial will be very interesting in that it is going to be short. Less than a day after application, they will know if the treatment has worked or not. They will watch the patient for a few days more until there are no more changes and also to accumulate data. Depending on the number of patients agreed to for the trial, it could end in 6 months or less. This is going to be exciting to watch.
    Sep 17, 2015. 01:29 PM | 2 Likes Like |Link to Comment
  • Coming Around (A Bit) On MagicJack VocalTec [View article]
    Furthermore, I find it really convenient with the apps installed in my iPad mini which I use a lot to take pictures and for emails. I made a trip to Canada recently and was able to talk to my friends in the US where ever there was wifi.... which was easy to find.
    Sep 15, 2015. 10:42 AM | 1 Like Like |Link to Comment
  • Ocata Therapeutics: Are You Watching A Bluebird Go By? [View article]
    If I may add to your reasoning, the Safety trial is done so two eyes will be safe to do together. In addition, the FDA will want to find out what happens when two eye are treated.... which is the ultimate goal. I believe AMD and SMD happen to both eyes together with a variation in degree of deterioration.
    Sep 10, 2015. 12:01 PM | 1 Like Like |Link to Comment
  • Ocata Therapeutics: Are You Watching A Bluebird Go By? [View article]
    Wotton did mention in I believe the 1st QTR C. that the vision improvement in all trial patients continues to hold. This implies that the 1st person to be treated with only 50,000 cells is still benefiting...4/5 years later.

    You mentioned that a re-treatment may be needed since one treatment may not last. It is possible. but the fact that OCAT is raising the dose to 300-400K could mean they are injecting enough cells to replace all the bad cells in the macula and because they are hESC cells (baby) they should last as long as the patient is alive.

    I do not know how many cells a typical macula has but I would think OCAT scientists would want to inject more than enough cells to insure all bad cells can and will be replaced to make vision restoration possible. Any excess cells will be naturally drain out of the eye.
    Sep 10, 2015. 11:40 AM | 1 Like Like |Link to Comment
  • Ocata Therapeutics: Are You Watching A Bluebird Go By? [View article]
    hmleod -- thanks for posting. This is quite a read but very educational and I can say that my knowledge of OCAT's venture in HMC's/treatment for Lupus has just jumped 10,000%!
    Sep 10, 2015. 11:17 AM | 1 Like Like |Link to Comment